Intellectual property for crop transformation: A continuing saga for agricultural innovation in the public sector by Bennett, Alan
03
Figure  shows Cohen and Boyer’s fundamental recombinant-DNA patent, issued in 
980. They were founders of the startup company Genentech. The patent was managed by 
Stanford and the University of California together. In a climate like today’s, it might have 
been licensed exclusively to Genentech. If it had, how many biotech companies would there 
now be?: one! In California alone, there are ,600. This was licensed on a non-exclusive 
basis for a very nominal charge. Such enabling technologies can support entire industries 
if they are widely available; otherwise, they support a very narrow base.
Figure  provides a snapshot of the intellectual-property landscape in agricultural 
biotechnology a few years ago. Pie A shows the landscape across the patent office as a 
whole, with approximately .5 percent assigned to the public sector. Pie B shows a very 
different landscape for ag-biotech, with a few large players with large intellectual-property 
portfolios. It has been speculated that the management of these intellectual-property 
portfolios has played a part in producing an industry that is relatively concentrated in a 
few players. Another different feature is that there is a large public-sector slice in Pie B, 
which is highly fragmented across universities (Pie C).
This gave rise to the formation the Public Intellectual Property Resource for Agriculture 
(PIPRA1) by the Rockefeller Foundation: could it take this public-sector portfolio and 
do something interesting with it—use it in strategic ways to enable not only the public 
sector but enable industries also?
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1PIPRA enables access to public innovation. PIPRA supports innovation in agriculture, health, water, and energy 
technologies. In collaboration with 50+ universities and research centers and a pro bono attorney network, 
PIPRA provides intellectual property rights and commercialization-strategy services to increase the impact of 
public-sector innovation, particularly for developing countries and specialty markets.
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Figure . Cohen and Boyer’s landmark patent for “producing biologically functional 
molecular chimeras.”
The first thing that the Rockefeller Foundation asked of PIPRA was to look at enabling 
technologies—the vectors, promoters, selectable markers, transformation methods, in-
cluding Agrobacterium, that can link novel traits with good germplasm. The request from 
the Rockefeller Foundation was to examine the public-sector portfolio to see if we could 
create something that has freedom to operate and could be widely used.
We started the process at the Danforth Center in St. Louis. The panel of experts who 
met comprised plant biologists and lawyers. The objective was to define applicable tech-
nical, legal and regulatory design parameters, similar to a standard-setting process that 
would be used in forming a patent pool in the electronics industry. The criteria drawn 
up included:
• Agrobacterium-mediated was preferred
• A wide range of promoters
• Clear of intellectual property (IP) blocks in the United States and elsewhere (the 
most essential feature)
• Plant products should be marker-free
• Desirable to have the possibility of “all plant” integrations.
We went through a process of gathering freedom-to-operate opinions from an attorney 
network who contributed their time on a pro bono basis, and then to define terms of 
technology and corporation into a patent pool. We formed a patent pool around these 
technologies, developed a transformation system, and published it (Chi-Ham et al., 
0). It has been distributed to a number of public-research institutions in the United 
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Figure . Recent intellectual property landscape in agricultural biotech.
States and internationally as well as to companies. Currently, it is the basis for seven trait 
incorporations: three that are essentially humanitarian products for Africa funded by 
USAID, and four commercial traits. Furthermore, the system has been used to generate 
a number of commercial events that are now in later-stage field-testing.
As mentioned, the published transformation system is Agrobacterium-based, an aspect 
on which the landscape has changed. Figure 3 shows the timeline of a broad and important 
patent application on Agrobacterium, filed in 983 not only in the United States but in 
many other countries as well. At that particular time, in the rest of the world, patents 
expired 0 years after application. So, in the rest of the world this patent has expired. 
However, in the United States under the pre-995 law, patents have a term of 7 years 
from issuance, and so it will be in force in the United States until 09.
When we developed these vectors, it was during a period when there were no broad 
Agrobacterium patents. The ones that had existed had expired and this particular one had 
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Figure 3. Over 9 years of prosecution. Anticipated expiration date:
September 5, 09.
not yet been issued. And so, this is where the landscape has changed. This very broad, 
well deserved, patent was issued to Monsanto on September 5, 0 (Figure 4): Geneti-
cally Transformed Plants. Filed originally in 985 as a continuation of an application filed 
in983, the patent was issued in 0, and, as discussed above, will stay in force until 
09. University researchers who use Agrobacterium to transform dicots are infringing on 
this patent. On the other hand, Monsanto is offering a free license to academic institu-
tions to use this methodology, which they intend to enforce. Infringing researchers are 
likely to hear from Monsanto. This raises the issue of the terms of that license. In fact, the 
conditions are reasonable and we have been working with Monsanto to improve them.
Figure 5 shows the scope of claims. It talks about genetically-transforming dicots by 
contact with Agrobacterium and incorporating Agrobacterium T-DNA borders; so, it’s 
very broad.
Inventing Around
The broad coverage (Figure 6, arrowed fields) has prompted examination of prospects to 
“invent around” (Figure 6, “X”). There may be opportunities to replace Agrobacterium 
with other bacterial genera. It talks about T-DNA from Agrobacterium. This suggests there 
may be opportunities to invent around utilizing either P-DNA or, potentially, synthetic 
borders. In fact, alternatives to Agrobacterium have been pursued for some time. In 005, 
Richard Jefferson and colleagues published a paper and filed patents on using Rhizobium 
species to harbor a Ti plasmid for delivery of transgenes to plants (Figure 7). This was 
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Figure 4. Recently issued patent.
the basis of what he called BiOS or open-innovation platform. However, efficiency was 
low and the concept failed to gain traction.
In 0, a group in Ireland (led by Ewen Mullins) published on and patented Ensifer 
adhaerens—closely related to the Rhizobium/Agrobacterium group—claiming broad 
 applicability for gene transfer. Figure 8 includes data generated with potato.
Another area to invent around is P-DNA or synthetic DNA borders (Figure 6), which 
has been the topic of important publications (Figure 9). Because we keep a watch on these 
things, we have noticed that one of the seminal papers on this topic has been retracted, 
which may affect the patent. If these move into the public domain, they would probably 
constitute a complete workaround.
Other PIPRA Activities
PIPRA provides intellectual property support to a number of agencies and universities. 
One the reasons that the Rockefeller Foundation became interested in intellectual prop-
erty was the Golden Rice story and the intellectual property audit that identified a large 
number of proprietary technologies that were infringed (Figure 0). Ingo Potrykus agrees 
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Figure 5. Patent No. 873954, Genetically Transformed Plants: Scope of claims.
with Dennis Gonsalves2 that intellectual property was not the main issue preventing the 
advancement of this innovation. In spite of the large number of proprietary technologies 
involved, it was quickly realized that Golden Rice could be “rebuilt” using approximately 
five proprietary technologies instead of seventy. As suggested by Scott Thenell3 regard-
ing planning innovations to address regulatory issues, forethought may also minimize 
intellectual property issues. PIPRA makes a lot of freedom-to-operate assessments for 
public-sector projects to determine if products or processes use third-party proprietary 
technologies and, if so, can the project obtain the rights to those properties? We look at 
intellectual property landscapes and patents, but we also look at materials used and mate-
rial transfer agreements, which, it turns out, are always the more problematic.
Anyone who has used a Gateway vector has agreed to the conditions set out in Figure . 
This license says that the buyer cannot sell or otherwise transfer materials made using this 
product or its components to a third party or for any commercial purposes.
Figure  provides a list of about half of our freedom-to-operate (FTO) assessments, 
many of which were for the Bill and Linda Gates Foundation. Others were for the Depart-
ment of Energy, which is now involved in a number of projects. The common feature of 
these projects is that they are funding research with commercial intentions. The agencies, 
of course, are interested in basic findings but they also want to see products that solve 
real problems. As a result, they’ve gotten quite involved in looking at FTO assessments 
before the research starts, i.e. addressing up-front issues and minimizing downstream 




Figure 6. Preliminary analysis: Scope of claims.
Inventing Around
Education and Outreach
Another area of PIPRA involvement is education and outreach. Figure 3 shows a two-
volume set of Best Practices handbooks that we published in 007. We run a licensing 
academy for technology managers from developing countries. The academy currently 
has forty students from twenty countries. There is great interest and significant hunger 
in understanding how to manage intellectual property in developing countries. Accord-
ingly, awareness is increasing. A lot of countries are focusing on increasing their capacity 
so that they can address their own innovations. Not only are they interested in using our 
innovations, but they want to protect and exploit their own.
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Figure 8. Transformation of potato with Ensifer adhaerens.
Figure 7. Alternatives to Agrobacterium for gene delivery.

Figure 9. T-DNA replacement with “P-DNA” or synthetic DNA borders.
Figure 0. Intellectual property creates challenges for public research and
missed opportunities for crop development.
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Figure . A “shrink wrapped” license.
Gene Patents
PIPRA is involved in a few genome projects and the issues of gene patents. Patent claims 
are appropriating public science at a fast pace. Figure 4 shows a famous patent applica-
tion, sometimes referred to as “the patent from hell.” This is a claim for a transgenic plant 
having an improved trait by expressing any of these genes or any related gene with 65 
percent homology. These are sometimes called “jumbo” patents. 
Figure 5 illustrates the situation for Arabidopsis- and rice-gene patents. Those in blue 
(88) are patents that were issued before the public release of the Arabidopsis genome. Four 
hundred and forty patents were issued on Arabidopsis genes after the public release of the 
genome. The same applies for rice: 84 before and 83 after. This raises the issue of the 
implications of public release of a genome, i.e. putting data on the Internet that provides 
opportunities for appropriating gene ownership.
Genome Projects
PIPRA has been working with the cacao-genome project and will be working with other 
similar projects soon. The cacao genome sequence was completed a few years ago for 
the express purpose of making it publicly available. And so, the sponsors of this genome 
asked PIPRA what it means to be publicly available. We worked with them to develop 
a portal for this genome, which involves an information access agreement with terms 
and conditions:
The user shall not claim legal ownership over the information and data. And the 
user agrees not to claim any sequences in any patent application. On the other 
hand, the foregoing shall not prevent the user from releasing, reproducing, seeking 
intellectual property protection on improved seeds or plants that are developed 
using this information.
The goal is to protect upstream information that can be thought of as research tools and 
enabling technologies to ensure that they remain publicly available and focus on protec-
tion, commercialization and exploitation of downstream products for purposes of making 
such seeds or plants available to farmers for cultivation.
A large multi-sponsored project is on-going to sequence the genomes of some one 
hundred orphan crops in Africa, with the intent of using similar portals. These all may 
become moot points considering that the Supreme Court may disallow patenting of genes 
and other naturally occurring molecules. Patenting of cDNAs and the like, which don’t 
occur in nature, may be allowed. 
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Figure . Freedom to operate—project assessment/enablement.
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Figure 3. Intellectual Property Management in Health and Agricultural Innovation:
A Handbook of Best Practices.
Figure 5. Number of US patents with word arabidopsis or rice in claims.
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Figure 4. Patent claims are appropriating public science at a fast pace.
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In Summary
The intellectual-property landscape for transformation has shifted. Sponsors of transla-
tional research are increasingly interested in clearing IP barriers in advance of making 
grant awards. And plant-gene patents may become moot, if the Supreme Court rules 
similarly to their opinion on human genes. 
Reference
Chi-Ham CL et al. (0) An intellectual property sharing initiative in agricultural bio-
technology: development of broad accessible technologies for plant transformation. 
Plant Biotechnology Journal 0(5) 50–50.
